Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

179.62 -1.78 (-0.98%)
Official Closing Price Updated: 7:00 PM EDT, May 25, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,558,995
Open 180.53
Bid (Size) 179.10 (10)
Ask (Size) 179.70 (1)
Prev. Close 181.40
Today's Range 179.06 - 181.55
52wk Range 155.72 - 186.69
Shares Outstanding 2,628,679,824
Dividend Yield 2.25%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Teva, Allergan Settle Opioid Lawsuit With West Virginia
U.S. affiliate of Teva Pharmaceutical Industries Ltd (NYSE: TEVA) has reached an agreement with the Attorney General of West Virginia that settles the state's opioid-related claims. 
Via Benzinga
US Raises Objection To Johnson & Johnson's High Cost Lawyer For Talc Bankruptcy Case: Reuters
Johnson & Johnson (NYSE: JNJ) is ready to cough up an hourly rate of $2,465 in a bid to add Hogan Lovells partner Neal Katyal to its legal team for the talc liability case. 
Via Benzinga

Performance

YTD
+4.71%
+4.71%
1 Month
-3.44%
-3.44%
3 Month
+11.41%
+11.41%
6 Month
+12.09%
+12.09%
1 Year
+5.61%
+5.61%

More News

Read More
Fortune 500 List Includes Cryptocurrency Company For The First Time; 30 Return After Missing 2021
Via Benzinga
These 5 Dividend Growth Stocks Could Be Owned “Forever”
Via Talk Markets
Positive Phase 2 Results Of SciSparc's Cannabinoid-Based Drug Candidate May Offer Some New Hope To Tourette Syndrome Patients
Via Benzinga
CNBC's Final Trades: O'Reilly Automotive, Best Buy, JPMorgan Chase And This 'Top-Notch' Pharma Stock
Via Benzinga
4 Top Stock Trades for Wednesday: FB, JNJ, CCL, NCLH
Via InvestorPlace
9 Stocks Moved By Traders On 'Fast Money: Halftime Report'
Via Benzinga
Healthcare Outperformance May Signal Short-Term Market Bottom
Via Talk Markets
Amid Monkeypox Outbreak, This 3X Leveraged ETF Provides Exposure To Health Sector: What To Watch
Via Benzinga
ImmixBio's Lead Candidate Shows Improved Survival Over FDA-Approved Soft Tissue Cancer Drug
Via Benzinga
What Are Whales Doing With Johnson & Johnson
Via Benzinga
Thoughts For Thursday: Ugly and Uglier
Via Talk Markets
3 Safe Stocks to Buy As We Head For a Recession
Via Talk Markets
Sector Rotation And 9 Stocks To Watch During A Recession
Via Benzinga
5 Stocks to Buy for the Coming Recession
Via InvestorPlace
Psychedelics Atai Life Sciences: Optimizing Drug Development By Avoiding Big Pharma's Past Missteps
Via Benzinga
SciSparc Reports Developing Cannabinoids Based Acute Pain Relief Alternative To Help Counter Opioid Crisis
Via Benzinga
8 Analysts Have This to Say About Johnson & Johnson
Via Benzinga
Point of Care Diagnostics Market Research Insight 2022| Key Players are Abbott Laboratories, Nova Biomedical, Chembio Diagnostic Systems, Inc., Danaher Corporation, Ekf Diagnostics Holdings Plc, Werfenlife, S.A., Johnson & Johnson Services, Inc., Hoff
Via iCrowdNewswire
Dollar Gains Traction As Fed Aims To Tame Inflation
Via Talk Markets
Inflation May Have Peaked: What to Do Now
Via InvestorPlace
Johnson & Johnson Stock: A Rare Bright Spot in the Market
Via InvestorPlace
Wall Street Extends Weekly Losing Streak Despite Upbeat Session
Via Talk Markets
Biden Says US Ready To Share COVID-19 Vaccine Related Technology
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.